1. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.
- Author
-
Cai Y, Shen X, Ding C, Qi C, Li K, Li X, Jala VR, Zhang HG, Wang T, Zheng J, and Yan J
- Subjects
- Animals, Dermatitis pathology, Humans, Interleukin-17 immunology, Interleukin-17 metabolism, Interleukin-23 biosynthesis, Interleukin-23 immunology, Macrophages immunology, Mice, Mice, Knockout, Phenotype, Psoriasis immunology, Psoriasis pathology, Receptors, Antigen, T-Cell, gamma-delta deficiency, Receptors, Interleukin-17 immunology, T-Lymphocytes metabolism, Dermatitis immunology, Interleukin-17 biosynthesis, Receptors, Antigen, T-Cell, gamma-delta immunology, T-Lymphocytes immunology
- Abstract
Interleukin-23 (IL-23) and CD4(+) T helper 17 (Th17) cells are thought to be critical in psoriasis pathogenesis. Here, we report that IL-23 predominantly stimulated dermal γδ T cells to produce IL-17 that led to disease progression. Dermal γδ T cells constitutively expressed the IL-23 receptor (IL-23R) and transcriptional factor RORγt. IL-17 production from dermal γδ T cells was independent of αβ T cells. The epidermal hyperplasia and inflammation induced by IL-23 were significantly decreased in T cell receptor δ-deficient (Tcrd(-/-)) and IL-17 receptor-deficient (Il17ra(-/-)) mice but occurred normally in Tcra(-/-) mice. Imiquimod-induced skin pathology was also significantly decreased in Tcrd(-/-) mice. Perhaps further promoting disease progression, IL-23 stimulated dermal γδ T cell expansion. In psoriasis patients, γδ T cells were greatly increased in affected skin and produced large amounts of IL-17. Thus, IL-23-responsive dermal γδ T cells are the major IL-17 producers in the skin and may represent a novel target for the treatment of psoriasis., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF